Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
<p><strong>Objective</strong> To investigate whether intravenous immunoglobulin (IVIG) improves neurological outcomes in children with encephalitis when administered early in the illness.</p> <p><strong>Design</strong> Phase 3b multicentre,...
Main Authors: | Hill, M, Iro, M, Sadarangani, M, Absoud, M, Cantrell, L, Chong, K, Clark, C, Easton, A, Gray, V, Kneen, R, Lim, M, Liu, X, Pike, M, Solomon, T, Vincent, A, Willis, L, Yu, L-M, Pollard, AJ |
---|---|
Other Authors: | IgNiTE study team |
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2023
|
Similar Items
-
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
by: Iro, MA, et al.
Published: (2024) -
ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial.
by: Iro, M, et al.
Published: (2016) -
Intravenous immunoglobulin for the treatment of childhood encephalitis
by: Iro, M, et al.
Published: (2017) -
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
by: Simon Nadel, et al.
Published: (2023-11-01) -
Childhood encephalitis in the United Kingdom - epidemiology, trends in hospital admissions and the role of intravenous immunoglobulin
by: Iro, M
Published: (2018)